Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)

Clinical trial NCT05518032 · WITHDRAWN

Trial details

NCT number: NCT05518032
Sponsor: Roswell Park Cancer Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Microsatellite Stable Colorectal Carcinoma Recurrent Colorectal Carcinoma Stage III Colorectal Cancer AJCC v8 Stage IV Colorectal Cancer AJCC v8 Unresectable Colorectal Carcinoma

Start date: 2024-10-01
Primary completion: 2026-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.